Philips Healthcare To Invest $60 Million ( Rs 380 Cr App) In Manufacturing Plant In Pune
- byDoctor News Daily Team
- 04 July, 2025
- 0 Comments
- 0 Mins
In the next three to four years, Philips Healthcare will double the capacity of the plant in Pune and introduce more business lines such as ultrasound machines, CT scans and MRIs from the facility
Philips Healthcare, the $300 million revenue arm of Philips Capital India, is looking at doubling the capacity of its Pune facility at an investment of $60 million in the next three to four years. During this course of time, the company plans to increase its business line including, ultra-sound machines, CT scans, and MRI’s under its production ambit.
Philips Healthcare has also announced its intention to scale up its operations under the PPP model to keep its growth rate healthy. It has pegged revenue growth at 18 per cent for the current fiscal, witnessing a double digit growth year-on-year for the past four to five years.
The Pune facility will include the new product line from the currently manufacturing medical products like the high-end cath labs and mobile surgery, which presently serve the neighboring markets such as Sri Lanka, Bangladesh, Nepal and Bhutan.
Asked what will be the main drivers of growth, Philips Capital India Chief Executive Officer Chhitiz Kumar told PTI: "At a macro level, the economy seems to be turning around. We are also making a lot of locally-relevant products locally."
The company is also looking at adopting new business models for growth, he added.
"We are very focussed on adopting new business models in the country such as PPP in the healthcare sector. We, along with the Manipal group, are setting up seven radiology centres in Haryana," Kumar said.
The next state the company is looking at for PPP model implementation is Jharkhand.
Philips India is a subsidiary of Royal Philips of the Netherlands, a diversified technology company, focussed on improving people's lives through innovation in healthcare, consumer lifestyle and lighting.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Tags:
Recent News
Pfizer files lawsuit against Metsera, its Director...
- 02 November, 2025
Health Ministry achieves 3 Guinness World Records...
- 02 November, 2025
Roche gets CE mark for Elecsys Dengue Ag test to d...
- 02 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!